drugset / Trial / NCT01288885

First in Men Study of Single Oral Doses of ASP1941 in Healthy Subjects

NCT01288885

Phase 1 Completed 76 enrolled Astellas Pharma Inc
RandomizedSingle-groupDouble-blindBasic science

Summary

This study determined the safety, tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of ASP1941 after a single oral dose (Part A). In addition, it was investigated whether the intake of food had an effect on the PK of ASP1941 (Part B).

Timeline

Start
2006-11
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule Oral

Indications

No indication recorded.